Tue, Jul 29, 2014, 2:21 AM EDT - U.S. Markets open in 7 hrs 9 mins


% | $
Click the to save as a favorite.

Celsion Corp. Message Board

  • biotekker biotekker Jan 18, 2013 5:10 PM Flag

    Just another example of Aschoff at Brean using a fake $1 target to tank a stock.

    From 2009-
    "As late as the day before the positive Dendreon data on its prostate cancer treatment Provenge came out, biotech analyst Jonathan Aschoff at Brean Murray Carret & Co. reiterated his "Sell" rating and $1 price target on the stock in a research note to clients."

    Once Brean was done flash crashing DNDN in the day leading up to the event and switching from short to long, they then repealed their $1 rec and switched back to a buy. SCAMMERS!

3.47+0.08(+2.36%)Jul 28 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.